Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo

por Kiziltepe, T, Ashley, J D, Stefanick, J F, Qi, Y M, Alves, N J, Handlogten, M W, Suckow, M A, Navari, R M, Bilgicer, B
Publicado 2012